Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza granted FDA priority review for PROpel
Investegate announcements from AstraZeneca PLC, Lynparza granted FDA priority review for PROpel
Source: investegate.co.uk
Page 4 - World Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from World Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In World Use Today - Breaking & Trending Today
PROpel Phase III trial positive results of Lynparza plus abiraterone in 1st-line metastatic castration-resistant prostate cancer published in New England Journal of Medicine Evidence
Results from the PROpel Phase III trial showed that AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone significantly improved radiographic progression-free survival (rPFS) versus abiraterone alone as a 1st-line treatment for patients with metastatic castration-resistant prostate cancer ...
Source: pharmiweb.com
Alien Gear Rapid Force Holster Review
The Rapid Force is the first duty style holster from Alien Gear. After several months of testing, how does it hold up to the competition?
Source: ammoland.com
Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex (cannabidiol) Oral Solution Data at the 2021 American Epilepsy Society Annual Meeting
Data from six abstracts advancing cannabidiol (CBD) research to be presented, including two abstracts which highlight results from a U.S. caregiver survey that provides insight on real-world
Source: finanznachrichten.de
Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex® (cannabidiol) Oral Solution Data at the 2021 American Epilepsy Society Annual Meeting
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six company-sponsored Epidiolex® (cannabidiol) oral solution presentations,...
Source: prnewswire.com